Radionetics Oncology has initiated a Phase 1 clinical trial for 68Ga-R8760, a pioneering radioligand imaging agent designed to detect adrenocortical carcinoma. The study, R8760-101 (NCT05999292), focuses on assessing the agent’s safety and dosimetry. Dr….
Continue Reading
Recent research from Sweden’s Linköping University reveals the thymus, often overlooked in adults, plays a crucial role in the immune system. As the thymus transforms glandular tissue into fat with age, sex, age, and…
Continue Reading
Incorporating remote patient monitoring (RPM) and artificial intelligence (AI) offers promising solutions to the challenges posed by chronic respiratory conditions like COPD, asthma, and chronic cough. By continuously and unobtrusively tracking symptoms, RPM can…
Continue Reading
Clinician-scientists from Japan and Singapore have set out to test the viability of robotic telesurgery as a treatment option.Last week, a surgical team from the National University Hospital (NUH), the flagship hospital of the…
Continue Reading
We’ve all been there: you arrive at a healthcare provider for an appointment, and there’s no one available at the check-in area. You might just see a kiosk to check in. Imagine, now, how…
Continue Reading
Health systems are increasingly realizing the importance of integrating behavioral care into primary care. Physical and mental health are interconnected, and addressing one without the other can lead to incomplete or less effective treatment….
Continue Reading
Ventricle Health, a virtual platform focused on cardiac care, secured $8 million in seed funding led by RA Capital Management with participation from Waterline Ventures alongside other investors. The company offers value-based home and virtual…
Continue Reading
Top News
Waystar announces that it filed IPO documents in August that reportedly value the company at up to $8 billion.
Waystar says it booked $196 million in sales for the quarter ending June 30…
What You Should Know:
– Densitas®, a provider of artificial intelligence solutions for breast cancer screening, announced a strategic partnership with Intelerad Medical Systems®, a provider of medical imaging software and services to advance AI-driven…
Continue Reading
Evident Vascular, a company creating AI-enabled intravascular ultrasound technology, announced its launch today with $35 million in Series A financing. Vensana Capital led the round.
WHAT IT DOES
The California-based company devised AI-enabled transcatheter intravascular ultrasound technology…
